Waystar Weighs Sale Amid Decline in Market Value

Healthcare software company Waystar is considering various strategic options, including a potential sale, just two years after its debut on the stock market, according to sources familiar with the matter. The firm, which provides technology solutions to streamline administrative tasks for hospitals and physicians, has engaged investment bank Evercore to assist with the process. Currently, discussions are in preliminary stages, and no final decision has been made.

Market Challenges and Strategic Positioning

Waystar, headquartered in Lehi, Utah, and Louisville, Kentucky, has seen its market value decrease to approximately $4.8 billion following a 24% drop in share prices this year. This decline aligns with a broader downturn in the software industry, as investors express concerns over the potential impact of advancements in artificial intelligence on traditional software business models.

The company has worked to position itself as a technology firm focused on automating administrative workflows, a strategy intended to attract higher valuations typically associated with tech companies. Initially, this approach was well-received, with share prices rising from $20 to a peak of $45 in 2025. However, recent market conditions have put pressure on its stock performance.

Ownership and Investment Background

Waystar was created in 2017 through the merger of revenue management companies Zirmed and Navicure. Its major shareholders include EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital, who took the company public in 2024. EQT holds a 13% stake, making it the largest shareholder, followed by CPPIB with 10% and BlackRock Institutional Trust Company with 8%, as per data from LSEG.

Neither Waystar nor its investors have commented on the potential sale, and Evercore has not responded to inquiries regarding the matter. The outcome of any potential sale remains uncertain, as the company evaluates investor interest in the software sector amid current market dynamics.

Potential Implications of a Sale

Should Waystar proceed with a sale, it could return to private ownership, a move that might allow it to recalibrate its strategy away from public market pressures. The auction process could also serve as a barometer for current investor sentiment towards software companies, particularly those in the healthcare sector, as they navigate technological disruptions and market volatility.

As the situation develops, stakeholders in the healthcare and investment communities will be closely monitoring Waystar's decisions, given its significant role in healthcare revenue management and the broader implications for technology-driven administrative solutions in the industry.